75 results
Page 2 of 4
6-K
EX-99.1
8hlzcko3y gq1w3pax8
9 Jun 22
SciSparc’s Board of Directors Provides Strategic Decision
8:38am
6-K
EX-99.1
njr3ok01kz vt6r85
1 Jun 22
SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems
4:11pm
6-K
EX-99.1
pm2nos979sz
11 May 22
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields New Patent Application for Psychedelic Combination Treatment for Binge Behaviors
1:58pm
6-K
EX-99.1
7x0j8ogylqb
1 Apr 22
SciSparc Announces Closing of New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
6:02am
6-K
EX-99.1
bba2mu6tdbwz2 scl2
10 Mar 22
SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
10:16am
6-K
EX-99.1
honkvsv 5pf4
9 Mar 22
SciSparc Enters Collaboration for the Development of Innovative Psychedelic-Based Pharmaceuticals
10:59am
6-K
f0r7 d3ti
9 Mar 22
SciSparc Enters Collaboration for the Development of Innovative Psychedelic-Based Pharmaceuticals
10:59am
6-K
EX-99.1
3nkgaw68ljuom
22 Feb 22
Report of Foreign Private Issuer
9:05am
6-K
EX-99.1
2l5qwaa8
6 Jan 22
SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer’s Disease
9:09am
6-K
EX-99.1
8hf9p
4 Jan 22
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
4:42pm
6-K/A
EX-99.1
ax6yaq66zhb
26 Aug 21
Current report (foreign) (amended)
4:42pm
6-K
EX-99.2
rjuoe0mu
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
0vimgbj tq7t5
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.1
mixedl6sxflkd45nj
7 Jul 21
Current Report of Private Issuer
4:00pm
6-K
EX-99.1
re987
24 Feb 21
SciSparc Corporate Presentation February 2021
9:27am
6-K
EX-99.1
5usloqyy 1t
17 Feb 21
Report of Foreign Private Issuer
8:35am
6-K
EX-99.1
u2pxvqh
11 Feb 21
SciSparc Announces Rebranding and Business Updates
10:01am
6-K
EX-99.1
57c2ddyz gf4cc
10 Feb 21
SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate
8:33am